Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
about
Surfactant therapy via brief tracheal catheterization in preterm infants with or at risk of respiratory distress syndromeNebulised surfactant in preterm infants with or at risk of respiratory distress syndromeLaryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromePharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeLaryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromePharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeNebulised surfactant for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromeEarly surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndromePhysiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress SyndromeTechnique for intrapartum administration of surfactant without requirement for an endotracheal tube.Continuous distending pressurePredictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study.Should we reconsider awake neonatal intubation? A review of the evidence and treatment strategies.The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome.Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants.Comparing minimally invasive and proactive initial management of extremely preterm infants.Nasal CPAP in newborns with acute respiratory failure.Initial respiratory management in preterm infants and bronchopulmonary dysplasia.Nasal CPAP for neonates: what do we know in 2003?A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal unitsProphylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trialSurfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.The importance of administration of early surfactant and nasal continuous positive airway pressure in newborns with respiratory distress syndrome.The 5 W's of surfactant for respiratory distress syndrome of the premature infant.Early hyperoxia burden detected by cerebral near-infrared spectroscopy is superior to pulse oximetry for prediction of severe retinopathy of prematurity.History of surfactant from 1980.European perspective on less invasive surfactant administration-a survey.Expression of SP-C and Ki67 in lungs of preterm infants dying from respiratory distress syndromeContinuous positive airway pressure: early, late, or stay with synchronized intermittent mandatory ventilation?Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.Impact of changes in perinatal care on neonatal respiratory outcome and survival of preterm newborns: an overview of 15 years.In Vitro Evaluation of a Device for Intra-Pulmonary Aerosol Generation and Delivery.Short- and intermediate-term outcomes of preterm infants receiving positive pressure ventilation in the delivery room.Evaluation of a practice guideline for the management of respiratory distress syndrome in preterm infants: A quality improvement initiativeEffect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.Use of Nasal Bubble CPAP in Children with Hypoxemic Clinical Pneumonia-Report from a Resource Limited Set-Up.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.To tube or not to tube babies with respiratory distress syndrome.RDS--CPAP or surfactant or both.
P2860
Q24188184-CC4FDE9D-09D4-4BE4-B239-7B1E2D991A69Q24198153-FB69D3EA-ADC5-4606-9118-170CF00CFF6DQ24235572-E3384CE6-DC92-4D7D-9654-ED16A932A76BQ24235658-BCBF0982-7E50-4FE9-AC8F-5D5C9BE87ADFQ24241523-DBCBF23D-300C-47DF-BBDA-0D2004F7110AQ24241537-1F1480F1-4C93-45C2-8370-2D6D16095D2CQ24241781-F2A48DDD-602D-4324-862B-CC443629DAFAQ24243075-E5E3FA79-7CED-4F27-9A8D-0C0E0A178A73Q28468426-A7E40F96-B4FF-4764-AB13-529CCD620DE8Q30433295-CE415830-CCCC-4FAC-819B-FBDDE2DDECDCQ33711528-2788BD38-19BF-434B-BE56-A0CD67806CF2Q33812145-55E7092E-0599-4CD9-B1D2-2168CA29371AQ34176230-F3861BD4-AE60-4D23-96A8-18426E76FCC4Q34538793-EB6DB3DC-07C8-491E-B869-64C353A1E2A6Q34613139-306D70B0-C299-416F-B3E8-13016DB96707Q34699188-2575F342-5C3F-4AA4-9D9F-AF881ED19FD9Q34742168-A619C899-32B9-44A6-919E-9F47C40A2FB2Q34945472-9D11C1FF-EC63-4332-A69B-072B1085A91AQ35028996-85E30C29-AF17-461D-87A2-448FE405861FQ35116511-8A3EF387-05B9-4652-BF5F-297E3A656018Q35293206-6A7A2026-8365-4065-8711-E92C8A65FDCAQ35295482-151A7001-E8D3-4B6D-B6C1-F26A381FE70EQ35627775-9719F73D-04E6-4E7E-A275-6F3E04EC8D51Q35712758-99FF36EF-E2FD-4C01-82D9-5C1E9970BE07Q35979950-2F4ACBEA-BC49-4D8A-93E1-68C01C0350DEQ36112508-6BA37F75-AEA3-464F-8FF2-A110CEA87506Q36178017-442329CD-913F-46F0-A3F5-98B324DC9B46Q36220353-EC88A4E4-67C5-4B29-B1CC-FBA295F0956AQ36386076-9144A16E-FA06-48F7-9266-E0965DFABF90Q36453813-A84115E4-D971-49E4-AAFE-E2BBF0AD202CQ36453825-0AB23386-12A0-4156-85FC-CD27E3967B34Q36516093-A88325CD-E151-43F7-8D57-467E93180EA4Q36578605-DEF80D10-9485-441F-B82D-D5F84F117BB1Q36582583-70412B15-1498-4DF1-BBF4-EABBD52F2294Q36592927-4A3A946A-528B-41F0-A2CE-6CAB88828E73Q36633714-EA6863D0-5482-4B00-9D1B-1785E47B8027Q37072456-B6A32F72-787A-447F-A4BF-85A83BE70934Q37341712-2291BF21-7817-43B1-A301-67EE66A03055Q37462142-90A00EB8-5F1C-4B5B-A7E6-FB342647B77AQ37992221-73F7326E-1238-4DC1-960D-81075FAE5457
P2860
Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@ast
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@en
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@nl
type
label
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@ast
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@en
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@nl
prefLabel
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@ast
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@en
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@nl
P2093
P1476
Surfactant therapy and nasal c ...... edish Multicenter Study Group.
@en
P2093
B Robertson
K Lundstrøm
P Albertsen
T Jacobsen
P304
P356
10.1056/NEJM199410203311603
P407
P50
P577
1994-10-01T00:00:00Z